Página 7 - Melhores Ressonância magnética cerebral médicos - TOP-193 médicos

O Professor Dihné é um verdadeiro mestre na compreensão dos mecanismos sutis do sistema nervoso. O seu profissionalismo manifesta-se no seu profundo conhecimento de anatomia e fisiologia, bem como na sua capacidade de identificar com precisão e tratar eficazmente doenças que podem afetar tanto o estado físico quanto psicológico do paciente. O Professor Dihné ouve atentamente todos, criando uma atmosfera de confiança, e com base em exames e análises minuciosos, desenvolve um plano de tratamento individualizado. Ele não só tem conhecimento nas mãos, como também a habilidade de sentir e entender como restaurar a harmonia no corpo e na mente de uma pessoa, devolvendo-lhe a qualidade de vida.

Associações a sociedades e prémios:

Sociedade Alemã de Médicos. 

Prémio de Investigação da Fundação Christian e Claudia Hempel por investigação de destaque no campo da pesquisa clínica de células estaminais.

Autor de numerosas publicações em revistas médicas de prestígio na Alemanha e na Europa.

Especialização:

• neurologia
• acidentes vasculares cerebrais
• epilepsia
• regeneração do sistema nervoso
• células estaminais
• matrizes de microeletrodos

Experiência profissional:

2001-2004: Treinamento no Centro de Neurobiologia Molecular em Hamburgo.

2004-2011: Treinamento na Clínica Universitária Neurológica de Düsseldorf.

2011-2013: Treinamento no Hospital Universitário Neurológico de Tübingen e no Instituto Hertie para Pesquisa Clínica do Cérebro. 

O Professor Dihne iniciou a sua carreira científica na Universidade de Düsseldorf. 

2013-2023  O Professor Dihne liderou com sucesso o Departamento de Neurologia na St. Lukas Klinik Solingen durante 10 anos.

Desde 2024: Médico Chefe no Departamento de Neurologia no Hospital Académico Solingen.

General Information and Presentation

He completed his primary education at Şenlikköy Primary School and his secondary education at the Istek Foundation Florya Bilge Kagan High School. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 2001. He completed his specialist education in Istanbul Medical Faculty Neurology Department in 2006. In 2006 he worked at the Neurology Clinic and the PharmaZentrum Research Center of the Faculty of Medicine of the University of Basel, Switzerland. Between 2007 and 2011, Bakırköy Prof. Dr. He worked at Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital in the 3rd Neurology Clinic and in the Dementia and Movement Disorders policlinics. Since October 2011, he has been working at Istanbul University of Science, Faculty of Medicine, Neurology, USA.

Experience

İstanbul Bilim University Faculty of Medicine Neurology, 

Şişli Florence Nightingale Hospital 

Kadıköy Florence Nightingale Hospital Neurology Clinics, 

Gayrettepe Metropolitan Florence Nightingale Hospital PET department.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Experiência Profissional Serviço Obrigatório 2014 - 15 Diretor de Saúde do Distrito - Centro de Saúde Comunitário de Güroymak/BİTLİS Especialização 2015 - 20 Faculdade de Medicina da Universidade de Fırat, Departamento de Neurocirurgia. Local de Trabalho 2024 - presente Hospital da Cidade de Eskişehir, Departamento de Neurocirurgia Educação Escola Secundária Anatolia Ataturk Siirt 2003 - 07 Faculdade de Medicina da Universidade de Fırat 2007 - 13 ARTIGOS CIENTÍFICOS • 1. Ozturk S, Erol FS, Akgun B, Surme MB, Artas G, Ozercan IH. Hemangioma Cavernoso Espinhal Intradural Extramedular Imitando Neurofibroma em um Paciente Diagnosticado com Neurofibromatose Tipo I. Revista Turca de Neurocirurgia 2016; 26:141-144. • 2. Akgun B, Ozturk S, Taskent I, Surme MB, Erol FS, Yildirim H. Avaliação dos Coeficientes de Difusão Aparente nas Amígdalas Cerebelosas e Bulbo em Malformações de Chiari Tipo I: Comparação Antes e Depois da Cirurgia. Turk Neurosurg. 2017 May 7. • 3. Surme MB, Hergünsel OB, Ertugrul B, Kaplan M. Hematoma Subdural Crônico Ossificante. Jornal de Neurologia Clínico da Turquia. 2017;12:44-48 • 4. Akgun B, Surme MB, Ozturk S, Erol FS. Hematomas Epidurais Espontâneos na Coluna Vertebral: Avaliação de 12 Casos. Jornal de Ciências da Saúde e Medicina da F.U. 2016; 30:107-111. • 5. Surme MB, Hergunsel OB, Akgun B, Kaplan M. Cranioplastia com Polimetilmetacrilato Pré-operativamente Personalizado Usando Molde de Tereftalato de Polietileno Glicol Impresso em 3D. J Neurosci Neurol Disord. 2018; 2:052-064. • 6. Bakal U, Poyraz AK, Tartar T, Akdeniz I, Surme MB, Çelik S. Uma Rara Complicação de Shunt Ventriculoperitoneal: Perfuração Assintomática do Intestino Delgado. Istanbul Med J 2019; 20(6): 571-3. • 7. De Lima L, Surme MB, Gessi M, Mastronuzzi A, Miele E, Tamburrini G, Massimi L. Tumor Neuroepitelial de Alto Grau do Sistema Nervoso Central com Alteração de BCOR (CNS HGNET-BCOR)—revisões baseadas em casos. Sistema Nervoso Infantil (2020) 36:1589–1599 • 8. Surme MB, Demir F, Erol D., Kaplan M. Existe uma Relação Genética Entre Leucemia Linfoblástica Aguda e Meningioma? Um Relato de Caso de 3 Análises de Genes. Arq Bras Neurocir 2021;00:1–3. • 9. Gurbuz O, Surme MB. O efeito da injeção de gel etanol radiopaco percutâneo intradiscal na dor em pacientes com hérnia de disco lombar: nossa experiência clínica. Eskisehir Med. J. 2022; 3(2):130-137. • 10. Arikan E, Surme MB. Avaliação dos Achados Clínicos e Radiológicos de Pacientes Diagnosticados com Hematoma Intracerebral Espontâneo. Mevlana Medical Sciences Journal 2 (2), 70-74. APRESENTAÇÕES ORAIS • Hergünsel OB, Ertugrul B, Surme MB, Kaplan M. Um Caso de Cefaleia Cervicogênica Tratada com Ressecção do Arco Posterior de C1. 30º Congresso Científico da Revista Turca de Neurocirurgia, 8-12 de abril de 2016, Antalya. • Ozturk S, Erol FS, Akgun B, Surme MB, Artas G, Ozercan İH. Hemangioma Cavernoso Espinhal Intradural Extramedular Imitando Neurofibroma em um Paciente Diagnosticado com Neurofibromatose Tipo I. 30º Congresso Científico da Sociedade Turca de Neurocirurgia. 8-12 de abril de 2016, Antalya. • Ertugrul B, Surme MB, Ozturk S, Kaplan M. Um Caso de Teratoma Sacrococcígeo Apresentando com Cauda Interglútea. 30º Congresso Científico da Sociedade Turca de Neurocirurgia. 8-12 de abril de 2016, Antalya. • Akgun B, Surme MB, Ozturk S, Demir F, Okcesiz I, Erol FS. Avaliação de Hérnias Discais Lombares Agudas com Ressonância Magnética Lombar de Espessura Fina. 12º Congresso Internacional Turco de Coluna Vertebral, 19-22 de abril de 2017, Antalya. • Akgun B, Ozturk S, Taskent I, Surme MB, Erol FS, Yildirim H. Avaliação dos Coeficientes de Difusão Aparente nas Amígdalas Cerebelosas e Bulbo em Malformações de Chiari Tipo I: Comparação Antes e Depois da Cirurgia. XVI. Congresso Mundial de Neurocirurgia, 20-25 de agosto de 2017, Istambul. • Akgun B, Surme MB, Ozturk S, Erol FS. Hematomas Epidurais Espontâneos na Coluna Vertebral: Avaliação de 12 Casos. 12º Congresso Internacional Turco de Coluna Vertebral. 19-22 de abril de 2017, Antalya. • Surme MB, Hergunsel OB, Celik S., Kaplan M, Erol FS. Avaliação de Casos com Spondilomielopatia Cervical que se Submeteram a Corporectomia - Nossa Experiência Clínica. 32º Congresso Científico da Sociedade Turca de Neurocirurgia. 20-24 de abril de 2018, Antalya. • Surme MB, Hergunsel OB, Akgun B, Kaplan M. Reparação de Defeitos Orbitofrontais Usando Enxertos de Polimetilmetacrilato Criados por Impressora 3D. 32º Congresso Científico da Sociedade Turca de Neurocirurgia. 20-24 de abril de 2018, Antalya. C I T A Ç Õ E S • Minhas publicações têm um total de 40 citações. CERTIFICADOS (OUTROS) • 1. Recebi um Bônus de Incentivo Acadêmico por 1 ano em 2017 por minhas publicações acadêmicas. • 2. Educação para Médicos do Centro de Saúde Comunitário. 14-18 de julho de 2014, Kars. (Instituição de Saúde Pública da Turquia). • 3. V. Simpósio de Doenças Zoonóticas da Turquia. 24 de outubro de 2015, Erzurum. (EKMUD- Associação Turca de Especialização em Doenças Infecciosas e TVHB - Associação Turca de Medicina Veterinária). • 4. Soluções de Ocupação Significativas Juntas. 15-17 de abril de 2015, Gothenburg/Suécia. (Programa de Aprendizagem ao Longo da Vida). • 5. Certificado de Realização (Posição: Gerente de Saúde do Distrito) 2015, Güroymak/ Bitlis • (Governadoria do Distrito de Güroymak) • 6. Entre 16.03.2019 - 04.04.2019, realizei meu serviço militar em Mamak/Ankara e recebi um 'Certificado de Apreciação'. CERTIFICADOS (NEUROCIRURGIA) • 1. Aneurismas Intracranianos e Neuroanatomia Vascular. 14-15 de janeiro de 2017, Mersin (Grupo de Treinamento de Educação em Neuroanatomia e Neurovascular TNDer). • 2. XII. Congresso Internacional Turco de Coluna Vertebral. 19-22 de abril de 2017, Antalya (Associação Turca de Coluna Vertebral). • 3. Certificado de Uso de Animais Experimentais. 10.12.2018 – 20.12.2018, Elazig (FÜSEM- Centro de Educação Continuada da Universidade de Fırat). • 4. 4ª Conferência Científica da Academia Turca de Neurocirurgia. 1-4 de novembro de 2018, Adana. • 5. Programa de Treinamento da Sociedade Turca de Neurocirurgia 6º Semestre 1º Módulo. 28.06.2018- 01.07.2018, Mudanya/Bursa. (Grupo de Cirurgia Espinhal e do Nervo Periférico). • 6. Programa de Treinamento da Associação Turca de Neurocirurgia 7º Semestre 2º Módulo 27.06.2019 – 30.06.2019, Van. (Grupo de Cirurgia Espinhal e do Nervo Periférico). • 7. Programa de Treinamento da Associação Turca de Neurocirurgia 8º Termo 1º Curso 2-5 de maio de 2019, Kayseri. (Grupo de Ensino e Treinamento de Neurocirurgia Pediátrica). • 8. Desenvolvimentos Atuais em Radiocirurgia com Faca Gamma. 30.11.2019, Elazig. (Faculdade de Medicina da Universidade Koç Prof. Dr. Selçuk Peker) • 9. 25º Simpósio Espinal da Sociedade Turca de Neurocirurgia 28-31 de outubro de 2021, Çeşme. (Grupo de Cirurgia Espinhal e do Nervo Periférico) • 10. Sociedade Turca de Neurocirurgia, 34º Congresso Científico. 30 de setembro - 3 de outubro de 2021, Online • 11. Associação Turca de Neurocirurgia, NOVA 19-22 de maio de 2022, Kütahya. (Palestrante) • 12. Curso de Manobras de Correção de Deformidade Espinal 21 de maio de 2022, Eskişehir. (Palestrante) • 13. Sociedade Turca de Neurocirurgia, 35º Congresso Científico. 24 – 27 de novembro de 2022, Antalya. (Palestrante) • 14. Cirurgia Espinhal Complexa, 4 de fevereiro de 2023, Eskişehir (Palestrante). • 15. Trabalhei como bolsista no departamento de Neurocirurgia Pediátrica da Universidade Católica (Roma/Itália) no Hospital Agostino Gemelli entre 15.01.2020 e 14.02.2020 por 1 mês. APRESENTAÇÕES ORAIS(2) • Surme MB, Ertugrul B, Sen D, Kaplan M. Existe uma Ligação Genética Entre Meningioma e Leucemia Linfoblástica Aguda? Uma Apresentação de Caso Envolvendo a Análise de 3 Genes. 33º Congresso Científico da Sociedade Turca de Neurocirurgia. 11-14 de abril de 2019, Antalya. • Ozturk S, Surme MB, Gönen M, Yıldırım H, Korkmaz S, Kocabıçak E. Análise das Mudanças de Perfusão em Matéria Branca e Cinzenta em Pacientes com Parkinson Tratados com Estimulação Cerebral Profunda do Núcleo Subtalâmico. 34º Congresso Científico da Sociedade Turca de Neurocirurgia. 30 de setembro - 3 de outubro de 2021, Online. • "Surme MB, Ustun ME. Caso de Insuficiência Vertebrobasilar Devido a Dolichoarteriopatia da Artéria Vertebral. NOVA 2022, Kütahya." • "Ustun ME, Surme MB. A insuficiência vertebrobasilar pode levar a sintomas semelhantes ao Parkinson? EANS 2022, Belgrado." • "Ustun ME, Surme MB. As estenoses da artéria vertebral têm origem aterosclerótica? EANS 2022, Belgrado." • "Surme MB, Yilmaz AH, Ustun ME. A Incontinência Urinária Resistente Poderia Estar Relacionada à Insuficiência Vertebrobasilar? Nossas Experiências Iniciais de Casos. 31º Congresso Nacional de Urologia. 27-30 de outubro de 2022, Chipre." • "Surme MB, Akgün B, Isci M, Baloglu M, Millet H. Avaliação da Eficácia das Abordagens Cirúrgicas na Mielopatia Cervical Espondilótica no Diâmetro do Canal Espinhal Cervical e na Intensidade de Sinal T2. 35º Congresso Científico da Sociedade Turca de Neurocirurgia. 24-27 de novembro de 2022, Antalya. • Surme MB, Cosar A, Daltaban IS, Ustun ME. Eficácia de uma Nova Técnica Cirúrgica para a Artéria Carótida * "Surme MB, Arikan E, Baloglu M, Millet H, Ercan S. Análise dos Achados Clínicos e Radiológicos em Casos 24-27 de novembro de 2022, Antalya. • "Surme MB, Cosar A, Ustun ME. A Insuficiência Vertebrobasilar Pode Causar Sintomas Semelhantes ao Parkinson? 35º Congresso Científico da Sociedade Turca de Neurocirurgia. 24-27 de novembro de 2022, Antalya. Diagnosticado com Hematoma Intracerebral Espontâneo. 35º Congresso Científico da Sociedade Turca de Neurocirurgia. Dolichoarteriopatias em Pacientes com Hemiparesia Moderada devido a Acidentes Isquêmicos Cerebrovasculares. 35º Congresso Científico da Sociedade Turca de Neurocirurgia. 24-27 de novembro de 2022, Antalya." • "Baloglu M, Millet H, Ercan S, Surme MB, Yayla E. O Efeito do MCI-186 na Peroxidação Lipídica em Ratos com Lesão Cerebral Traumática Experimental. 35º Congresso Científico da Sociedade Turca de Neurocirurgia. 24-27 de novembro de 2022, Antalya." * "Surme MB, Ustun ME. A Eletrocorticografia Quantitativa (ECoG) Pode Ser Mais Valiosa do que a ECoG Não Quantitativa? Um Relatório Preliminar. Construindo Pontes entre Neurociências e Neurocirurgia: Novas Fronteiras em Neurofisiologia Intraoperatória. 2-4 de fevereiro de 2023, Verona, Itália

Formação

• Faculdade de Medicina de Ege 1978
• Especialização em Pediatria 1982
• Subespecialidade em Oncologia Pediátrica 2002 (Faculdade de Medicina EU)
• Hematologia e Oncologia Pediátrica 2012 (Faculdade de Medicina EU)
• Chefe Adjunto de Clínica 1988 Tepecik EAH
• Chefe de Clínica 1993 Tepecik EAH
• Professor Associado 1995
• Professoria 2002
• Faculdade de Medicina da Universidade de Ege, membro do corpo docente 1998 – 2022
• Departamento de Pediatria da Faculdade de Medicina da UE 2009-2018
• Membro do Conselho de Planejamento e Coordenação de Educação Tepecik (1993-1998)
• Presidente do Comitê de Ética do SSI Hospital de Tepecik (1996-1998)
• Sociedade Turca de Hematologia Pediátrica "Co-Presidente do Grupo de Trabalho em Transplante de Medula Óssea" (2002-2006)
• Sociedade Turca de Hematologia Pediátrica "Grupo de Trabalho em Transplante de Medula Óssea" (2006-2008)
• Sociedade Turca de Hematologia Pediátrica - Responsável pelo Sistema de Registro de Dados "Online" de Transplante de Medula Óssea 2007-presente.
• Presidente da Comissão de Medicina Regenerativa e Células-Tronco da Universidade de Ege, 2011-2021

Filiações Institucionais

• Associação Médica Turca Ramo de Izmir e Kocaeli
• Associação Pediátrica Nacional Turca - İzmir
• Grupo Europeu para Transplante de Medula Óssea (EBMT); a Unidade de Transplante de Medula Óssea Pediátrica da Universidade de Ege foi credenciada pelo Grupo Europeu para Transplante de Medula Óssea (EBMT) em junho de 2007.
• Sociedade Turca de Hematologia Pediátrica - Membro do Conselho por dois mandatos (2005-2009)
• Sociedade Turca de Hematologia - Membro do Conselho por dois mandatos (2001/2005)
• Associação de Oncologia Pediátrica da Turquia
• Fundação de Transplante de Medula Óssea (KITVAK) Membro do Conselho de Curadores

Unidades que ele fundou                        

1- Clínica de Oncologia Pediátrica do SSI Hospital de Tepecik (1990) 
2- Unidade de Transplante de Medula Óssea Pediátrica do SSI Hospital de Tepecik (1992) 
3- Unidade de Transplante de Medula Óssea Pediátrica da Faculdade de Medicina da UE (1998) 
4- FUNDADOR do JOURNAL OF PEDIATRIC RESEARCH, 2014; foi feita a aplicação SCI em 2022. 

Unidades de Transplante que ele contribuiu para o estabelecimento de                        

1. Unidade de Transplante de Medula Óssea Pediátrica do İzmir BUÇH EAH (2019) 
2. Unidade de Transplante de Medula Óssea Pediátrica do Ümraniye EAH (2020) 
3. Unidade de Transplante de Medula Óssea Pediátrica do Kanuni Sultan Süleyman EAH (2020) (Transferida para Çam Sakura EAH)

Prémios

• Parâmetros trombóticos em pacientes com transplante de células-tronco de medula óssea, Congresso de Hematologia Pediátrica, Trabzon 2003
• Antígeno CD133 em Células-Tronco: Congresso de Hematologia Pediátrica 2005. Prémio de pesquisa
• O papel dos Receptores Toll-like em pacientes neutropênicos febris, Prémio de melhor poster. Congresso de Hematologia Turca 2008, Çeşme-İzmir
• Atividade nacional de transplante de células-tronco pediátrico- Apresentação oral segundo prémio, Congresso de Transplante de Células-Tronco da Sociedade de Hematologia Turca, 2022, Antalya

Publicações

Kansoy S. "Transplante de Medula Óssea e Células-Tronco Saúde Infantil e Doenças, 1ª edição, Casa de Impressão da Faculdade de Medicina da UE, 1999, Izmir

Kansoy S. Transplante de Medula Óssea na Talassemia Major III. Livro dos Dias de Talassemia do Egeu, 2000, Izmir

Kansoy S. Padrões da Pediatria KIT na Turquia. Leucemias Agudas da Infância, Antalya 2000: 73-5

Kansoy S. Efeitos tardios em crianças. Edição especial do Jornal de Transplante de Medula Óssea Clínicas Turcas. 2003

Kansoy S. Aplicações de Células-Tronco em Transplante de Medula Óssea e Células-Tronco. Livro do Curso de Enfermagem Oncológica Pediátrica, İzmir, 2005

Kansoy S. Sangue do Cordão Umbilical como Fonte de Células-Tronco. Edição Especial de Células-Tronco. Clínicas da Turquia, 2008

Kansoy S. Transplante de Células-Tronco em Linfomas. Livro de Pediatria Geral, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Transplante de Medula Óssea em Crianças. Pediatria, 2014 e 2017

Kansoy S. Rabdomiossarcoma. Pediatria, 2014 e 2017

Kansoy S. Abordagem à criança com câncer de acordo com os achados clínicos. Pediatria, 2014 e 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Doenças Oncológicas. Pediatria (Ed. A. Cura), 641-672, Casa de Impressão da Universidade de Ege, Izmir, 1999.  (1,05 pontos)

Kansoy S, M.Kantar. Exame de Cabeça, Face e Olho. Exame Físico Prosético Pediátrico e Informação de Sintomas (Ed. A.Cura)

Kantar M. Problemas de Emergência Metabólica em Oncologia. Emergências Oncológicas e Cuidados de Apoio na Infância (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, Izmir, 2003. 

Transplantes de Sangue do Cordão Umbilical na Turquia. HEMATOLOGISTA, 2016

Kansoy S. Tumores do Sistema Nervoso Central em Crianças Pediatria, 2014 e 2017

Leucemia Mieloblástica Aguda em Crianças e seu Tratamento. Livro Textbook de Oncologia Pediátrica, Turco de Poplack, 2020

Atividade nacional de transplante de células-tronco pediátrico, 2020

Indicações de transplante de células-tronco na infância, Clínicas da Turquia - Livro Internacional 2020

Além dos estudos e artigos em revistas internacionais publicadas em grande número, ele está envolvido em estudos multicêntricos internacionais em algumas revistas com alto valor de impacto.

Prof. Erkan Kaptanoğlu, M.D. was born in Balikesir, Turkey in 1966. After completing his primary school, secondary school and high school education in Balikesir, he graduated from Istanbul University, Cerrahpasa Faculty of Medicine in 1990. He completed his internship at Peterborough District Hospital and Lincoln County Hospital in the United Kingdom. After a year of compulsory medical service, he completed his residency, which he had started in 1992, at Ankara Numune Training and Research Hospital in 1997 and became a Neurosurgery Specialist. After being assigned at the same hospital as Chief Resident in the same year, he studied “spinal cord injury and spinal cord regeneration” as a “research fellow” alongside Prof. Charles Tator, M.D., at the University of Toronto Faculty of Medicine in 1998-1999. After returning from Canada in 1999, he was tasked by the Ministry of Health to establish a Field Hospital and to work in cooperation with the Turkish Red Crescent Society at Hakkari, Şemdinli for two months. Following this assignment, he volunteered to work for the 1999 Marmara Earthquake relief effort.

He became an Associate Professor of Neurosurgery in 2004. He earned the title Doctor of Science (Ph.D.) by completing a doctorate program on Advanced Neuroscience between 2000-2005, at Hacettepe University Institute of Medical Sciences. He joined the project for autologous stem cell therapy in human spinal cord injuries with the Departments of Neurosurgery and Hematology at the Ankara University Faculty of Medicine. In 2009, he was appointed as Deputy Chief to the 1st Neurosurgery Clinic at the Ankara Numune Hospital, where he had been working.

At this hospital, in which he worked until 2010, he supervised and attended complex cranial, pediatric, spinal, trauma and vascular neurosurgery operations. He continued his academic research at Ankara University, Department of Anatomy and research laboratories of Ankara University and Hacettepe University for the purpose of developing strategies for complex spinal surgery operations.

With his research on spinal cord injuries and spinal anatomy, he won many awards such as the Acibadem Hospital Medical Research Award, 1st Place in 2000, Turkish Neurosurgical Society Dr. Mahir Tevruz Scientific Research Award, Tübitak and Brain Research Society Wheyt Award in 2001, Turkish Neurosurgical Society Hamit Ziya Gokalp Young Neurosurgeons Research Award, 2nd Place in 2002, Turkish Neurosurgical Society Yildiz Yalcinlar Scientific Research Award in 2004.

In 2010, he went to Cyprus to found the Near East University Faculty of Medicine Hospital with the guidance of Hacettepe University, and was appointed as full Professor. Between 2010-2015, he served as the Founder and Head of Department at the Near East University and Founder and Deputy Chief Physician at the University Training and Research Hospital in TRNC.

In 2000-2001, he served as a member of the editorial board for Türk Nöroşirurji Dergisi and Turkish Neurosurgery journal. Between the years 2001-2006, he served as an assistant editor for Türk Nöroşirurji Dergisi and Turkish Neurosurgery journals. In 2002-2003, he served as the Chairman of the Young Neurosurgeons Committee under the Turkish Neurosurgical Society. He was elected to the Turkish Neurosurgical Society Spinal and Peripheral Nerve Surgery Group Board of Directors to serve between 2003-2009. In 2013, he was again elected as a member to the Turkish Neurosurgical Society Spinal and Peripheral Nerve Surgery Group Board of Directors. In 2015, he became the Chairman of the Turkish Neurosurgical Society Spinal and Peripheral Nerve Surgery Group Board of Directors. In 2018, he was elected as a member to the Board of Turkish Neurosurgery Academy.

In 2015, he was appointed to the Marmara University Faculty of Medicine, Department of Neurosurgery and was elected as the Head of Department. During the same period, he also served as the Director of the Institute of Neuroscience. In 2018, he completed his tenure as the Head of Department. Reaching the end of this tenure in 2019, he retired from his duties as the Director of the Institute of Neuroscience and as a Member of the Faculty of Medicine. During his tenure at Marmara University, he supervised and accompanied surgical operations for complex cases from cranial patients to brain tumors (gliomas, meningiomas and hypophysis adenomas in particular), cerebral hemorrhages, Parkinson’s disease, trauma and vascular neurosurgery. He performed complex spinal surgery operations such as surgeries for spinal deformities (e.g. scoliosis and kyphosis), thoracoscopic spinal surgeries and sacral tumor surgeries. He conducted research and experimental studies on stem cell therapy and regeneration in spinal cord injuries. Between 2019-2020, currently He continues his clinical practice and surgeries along with his local and international academic studies, from his private clinic and Istanbul Brain and Spine Center.

He has attended numerous national and international courses and meetings as an instructor and speaker, was a guest speaker in over 100 events and conferences. He has published 65 international, 35 national scientific articles, edited 7 books, written 52 book chapters. He has served in the organizational committee 5 times in international meetings and 22 times in national meetings.

He is a member of the Turkish Medical Association, Turkish Cypriot Medical Association, Turkish Neurosurgical Society, Turkish Spine Society, EUROSPINE, AO Spine, Turkish Neurosurgery Academy.

Work and Interest Areas

• Peripheral Arterial Diseases
• Neurovascular Interventions
• Oncologic Interventions
• Nonvascular Interventions

Education

• (2004 – 2011), Faculty of Medicine, Inonu University, Malatya, Turkey
• (2011 – 2015), Department of Radiology, Bagcilar Training and Research Hospital, Istanbul, Turkey

Experience

• (2016 – 2020), Diagnostic and Interventional Radiologist, Mus State Hospital, Mus, Turkey
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology, Sakarya University Training and Research Hospital, Sakarya, Turkey
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology, Sakarya University Training and Research Hospital, Sakarya, Turkey
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology, Medipol University Hospital, Istanbul, Turkey

Memberships in Scientific Organizations

• TSIR (Turkish Society of Interventional Radiology)
• TSR (Turkish Society of Radiology)
• CIRSE (Cardiovascular and Interventional Radiological Society of Europe)
• ESR (European Society of Radiology)
• ESNR (European Society of Neuroradiology)

Education:

Medical Specialization

Hacettepe University 2017 - 2007

Medical Specialization (Minor)

Ufuk University 2011 - 2009

Doctorate

Ankara University 2021 - 2000

Undergraduate

Ankara University 2006

Experience: 

Research Assistant

Biotechnology Department, Biotechnology Institute, Ankara University

September 01, 2009 - October 08, 2021

Research Assistant

Department of Pediatrics, Faculty of Medicine, Hacettepe University

February 27, 2014 - February 28, 2017

Research Assistant

Dr. Ridvan Ege Health Research and Application Center, Ufuk University

November 27, 2007 - December 09, 2011

Medical Area of Interest and Activities 

Functional Neurosurgery (Parkinson’s, Deep Brain Stimulation) 

Brain and Spinal tumors 

Spinal degenerative diseases Education 

Istanbul University Cerrahpaşa Faculty of Medicine 

Trakya University Faculty of Medicine Brain and Nerve Surgery

Education 

Istanbul University Cerrahpaşa Faculty of Medicine 

Trakya University Faculty of Medicine Brain and Nerve Surgery

Experience 

Ankara Gülhane Military Medical Academy Brain and Nerve Surgery 

Osmaniye State Hospital 

Bolu State Hospital 

Private Taksim German Hospital 

Taksim Training and Research Hospital 

Istanbul University Faculty of Medicine Brain and Nerve Surgery 

Liv Hospital Ulus

Memberships 

Turkish Neurosurgery Society 

Turkish Medical Association

Research and Publications 

Development of micro-neurosurgery laboratory training model for orbita and optical nerves on fresh lamb cadaver (2007) • 

Effect of Astaxanthin on NMDA sub units and MRNA expression levels in Primary Cortical Neurons 

Articles in International Journals (18)  

Chapters in International Books (1) 

Articles in National Journals (5) 

International Papers (12) 

National Papers (24) 

Specializations

Brain Tumors

Aneurysm Surgery

Pituitary Surgery

Spine Surgery

Waist neck and back hernias

Spine Tumors

Spinal Fractures

Peripheral Nerve Surgery

More details about the procedures performed:

• Diagnosis and treatment of neurological diseases in adults (inpatient and outpatient):
• Conducting local injection therapy (blockade), including paravertebral injections and treatment of compression-ischemic neuropathy of the upper and lower extremities (tunnel syndromes).
• Performing a lumbar puncture.
• Therapeutic massage and post-isometric muscle relaxation, as well as physical therapy instruction.
• Assistance in interpreting the results of CT, MRI, EMG/ENMG, EEG, TCD/ultrasound.
• Inpatient and outpatient care of patients with neurological diseases.

During his career, Dr. Covaro has a continuous participation in international meetings and contributed to several articles published in scientific magazines. Dr. Covaro is a member of several professional organizations, including the Spanish Society of Orthopedics, AOspine, GEER and Eurospine.

Currently, Dr. Covaro attends his patients at the Institut Universitari Dexeus and the Hospital Universitari de Bellvitge, in Barcelona. To make an appointment with Dr. Augusto Covaro, contact ICATME, Institut Universitari Dexeus

Educação e Especialização:

• Graduação em Medicina: Universidade de Istambul, Faculdade de Medicina Cerrahpaşa (1991-1998)
• Especialização em Neurocirurgia: Universidade Técnica de Karadeniz, Faculdade de Medicina (1999-2005)
• Docente Adjunto: (2015)
• Professoria: (2020)

Experiência Profissional:

• 2007-2008: Ankara GATA
• 2009-2011: Hospital Özel Ordu Medical Park
• 2011-2013: Hospital de Treinamento e Pesquisa de Keçiören, Ankara
• 2013-2015: Universidade de Giresun, Faculdade de Medicina
• 2014: Observador Clínico no Hospital Central da Universidade de Helsínquia
• 2015-2023: Universidade Técnica de Karadeniz, Faculdade de Medicina
• Cargo Atual: Neurocirurgião no Hospital VM Medical Park Pendik

Áreas de Especialização:

• Aneurisma Cerebral e Reparação
• Cirurgia de Tumores/Câncer Cerebral
• Cirurgia de Estenose do Canal Espinhal
• Hérnia de Disco Lombar e Cervical
• Cirurgia da Medula Espinhal
• Neurocirurgia Minimamente Invasiva
• Neurocirurgia Pediátrica
• Anomalias Congênitas

Pesquisa e Publicações: O Prof. Dr. Arslan tem inúmeras publicações em revistas conceituadas, cobrindo temas como o tratamento de tumores cerebrais e espinhais, técnicas neurocirúrgicas inovadoras e resultados de intervenções neurocirúrgicas. Seu trabalho inclui estudos sobre lesões por isquemia/reperfusão cerebral, isquemia da medula espinhal e várias outras condições neurocirúrgicas.

Associações Profissionais:

• Associação Turca de Neurocirurgia
• Sociedade Turca de Cirurgia Neurológica

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Eduardo Fernandez, MD

Medical Doctor & Stem Cell Expert

Dr. Eduardo Fernandez is a distinguished medical professional specializing in stem cell therapies and regenerative medicine. He is a certified member of the Mexican College of Stem Cells and Regenerative Medicine, as well as the Mexican Council of Stem Cells for Therapeutic and Research Purposes. Dr. Fernandez’s certifications are the result of a rigorous 8-hour examination process, reserved for a select group of doctors who possess advanced knowledge and experience in these cutting-edge treatments. With only 50 certified doctors in Mexico, Dr. Fernandez’s expertise is highly sought after and respected.

In addition to his national recognition, Dr. Fernandez is awaiting international certification from the renowned International Society for Stem Cell Research (ISSCR). Membership in this prestigious organization signifies Dr. Fernandez’s extensive experience and expertise in stem cell treatments. The ISSCR includes prominent scientists from renowned universities such as Harvard, Yale, Stanford, and other esteemed institutions worldwide. Being a part of this elite society represents the pinnacle of honor and prestige in the field of stem cell therapies.

Furthermore, Dr. Fernandez is also seeking membership and international certification from the International Society for Extracellular Vesicles (ISEV), the largest community of extracellular vesicle researchers globally. With only two thousand members worldwide, ISEV’s select nature underscores Dr. Fernandez’s exceptional dedication to advancing scientific knowledge in the study of exosomes and cellular messengers. By pursuing membership in ISEV, Dr. Fernandez continues to demonstrate his commitment to staying at the forefront of research and innovation in the field of regenerative medicine.

Parkinson's Disease Diagnosis and Treatments

Alzheimer's Diagnosis and Treatments

Epilepsy (Epileptic)

EEG and Treatment

Muscle and Nerve Disease Diagnosis and Treatments

Vertigo Diagnosis and Treatment

Restless Leg Syndrome

Stroke (Cerebral Palsy) Diagnosis and Treatment

Bartın State Hospital (2007-2009)

VM Medical Park Samsun Hospital (2009-2017)

VM Medical Park Samsun Hospital - Deputy Chief Physician (2019-2021)

Samsun Education and Research Hospital (2021-2022)

Çarşamba State Hospital

Private Atasam Samsun Hospital (2022-2024)

Karadeniz Technical University (1989-1995)

Ondokuz Mayis University Faculty of Medicine (2001-2006)

Experiência profissional

Desde 2006, é Chefe do Departamento de Neurologia do Hospital Universitário Quironsalud de Madrid e do Hospital Ruber Juan Bravo.

Professor de Medicina na Faculdade de Ciências Biomédicas da Universidade Europeia de Madrid, possui a acreditação nacional de Professor de Ciências Médicas (emitida pela ANECA).

Doutor em Medicina, Universidade Complutense de Madrid (UCM). Prêmio de Tese Doutoral Distinta (UCM, 2004): Estudo sobre a relação do vírus herpes humano 6 como fator ambiental na esclerose múltipla.

Filiação em sociedades científicas

Investigador Principal Nacional e Internacional em Neurociências no Quironsalud Madrid (junho de 2015 – presente)

Presidente do Comitê de Pesquisa do Hospital Universitário Quironsalud de Madrid (2012 até o presente).

Membro do Comitê de Pesquisa do Hospital Clínico San Carlos (2012-2015).

Membro do Conselho da Faculdade de Medicina da Universidade Complutense de Madrid (2011-2015).

Pesquisa e Ensino

Investigador principal de 100 ensaios clínicos nacionais e internacionais.

7 projetos de pesquisa FIS do Instituto de Saúde Carlos III (os últimos 5 como investigador principal).

10 projetos de fundações privadas, recebidos em base competitiva (7 como investigador principal).

Autor de 139 artigos internacionais com fator de impacto total de 949,917 e 4.552 citações. 38 livros e capítulos de livros com um fator H de 34 (2018).

Suas publicações destacam-se em revistas que têm o maior impacto global na pesquisa, como o New England Journal of Medicine e o Lancet.

O Dr. Rafael Arroyo realizou mais de 300 apresentações internacionais e nacionais em vários Congressos.

Formação Acadêmica:

Professor de Medicina na Faculdade de Ciências Biomédicas da Universidade Europeia de Madrid e possui a acreditação nacional de Professor de Ciências Médicas (emitida pela ANECA).